Archives
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-08
-
Although other risk markers such as high
2019-06-19

Although other risk markers such as high amplitude J waves in the inferior leads have been suggested, a better scheme for risk stratification is necessary. The presence of a type I BS ECG pattern indicates the necessity for ICD buy 5-Carboxymethylester-UTP in patients with syncope of unknown causes
-
Pharmacological inhibition of PI K
2019-06-18

Pharmacological inhibition of PI3Kα induces apoptosis of CLL L-745,870 trihydrochloride in vitro [5,18], and inhibits CLL migration towards CXCL12 [5]. The PI3Kα/δ inhibitor copanlisib induces significantly greater apoptosis of CLL cells compared to idelalisib (IC50 of 450nM and >10μM, respectively
-
5\'-Iodoresiniferatoxin In primary diagnosis IKZF status
2019-06-18

In primary diagnosis IKZF1 status was not taken into account for risk group stratification. According to protocol ALL-MB-2002 regulations, risk was underestimated and patient was assigned to the SRG. Prognostic value of IKZF1 alterations in ALL, especially BCR-ABL1 negative ALL, is still debated [19
-
Methods Between and Ridge Regional Hospital
2019-06-18

Methods Between 2013 and 2015, Ridge Regional Hospital adopted a quality improvement programme in three stages. In the first stage, two senior staff members were selected to serve as QI (quality improvement) leaders and received 4 days of training in Six Sigma methods. In the second stage, two front
-
Fig shows an example of RNRVAS in a dual chamber
2019-06-18

Fig. 3 shows an example of RNRVAS in a dual-chamber pacemaker recipient with sinus node disease, with the pacemaker set in rate adaptive DDI-R mode pacing with an AV interval of 300ms and lower rate limit of 60ppm. The tracing shows sensor-driven DDIR pacing at 80bpm (V–V Gallein manufacturer lengt
-
br Safety of continuation of
2019-06-18

Safety of continuation of warfarin during the perioperative period of pacemaker and defibrillator surgery An increasing body of literature has suggested that pacemaker and defibrillator c-kit inhibitor without cessation of oral anticoagulation is safe and feasible. Goldstein et al. were among th
-
br Discussion Clinically HES may
2019-06-18

Discussion Clinically, HES may be separated into two subgroups: HES with, and HES without gene abnormality such as PDGFRA, PDGFRB, or FGFR1. The standard therapy of HES without gene abnormality is steroid; by contrast, the first-line therapy of HES with gene abnormality is imatinib. Although in-
-
The patient started FOLFOX chemotherapy
2019-06-18

The patient started FOLFOX chemotherapy at another institute on September 14, 2015. However, he suddenly lost consciousness and his blood pressure plummeted; the electrocardiogram monitor showed ventricular tachycardia. After cardiopulmonary resuscitation, he regained spontaneous circulation and was
-
Reviewing the literature we knew that in cases of
2019-06-18

Reviewing the literature, we knew that in cases of AA, use of IST should be cautious, as IST might accelerate occult lymphoma escaping immune surveillance and evolving as a refractory lymphoma. Second, in cases of AA and concomitant NHL, to choose cytotoxic chemotherapy or IST is an art. Depending o
-
The exhibited efficacies of bone targeting treatments in
2019-06-18

The exhibited efficacies of bone targeting treatments, in phase III clinical trials, suggest significant progress in delaying skeletal-related events, with improvements having been seen in the direct comparisons between generations of drugs. These findings also lend clear support to the utility of b
-
br Dissemination permissive characteristics of the BM
2019-06-18

Dissemination-permissive characteristics of the BM vascular niche Sinusoids (type L capillaries) are the most abundant blood vessels in bone and widely distributed throughout the bone marrow cavity [8]. Sinusoids in bone are discontinuous single layer of endothelial buy SR 2595 devoid of pericyt
-
Acknowledgement br Introduction Pulmonary veins PVs
2019-06-18

Acknowledgement Introduction Pulmonary veins (PVs) have been reported to be the major site of ectopic foci initiating paroxysmal atrial fibrillation (AF) [1]. Pulmonary vein isolation (PVI) is an established therapy eliminating those foci [2,3]. Non-PV ectopic foci from the superior vena cava (S
-
En segundo lugar el marco paratextual a la tercera edici
2019-06-18

En segundo lugar, el marco paratextual VUF 10166 la tercera edición de la novela destaca la preocupación de Chateaubriand por la figura del viajero encargado de acercar las riquezas americanas a Europa. Para este autor, el artista es el intermediario por excelencia entre la naturaleza y la religión
-
Prednisone prephase was initiated and
2019-06-18

Prednisone prephase was initiated and led to immediate improvement of clinical status. However, tumour size did not decrease within the prolonged prephase of 11 days (Fig. 1b). Despite additional cyclophosphamide (2×200mg/m2), the patient showed deteriorating clinical condition and fever reappeared
-
br Conclusion br Conflict of
2019-06-17

Conclusion Conflict of interest Introduction Dermatofibrosarcoma protuberans (DFSP) is a rare soft-tissue neoplasm that was first identified by Taylor, RW in 1890. It was then described in 1924 by Darier, J and Ferrand, M as a progressive recurrent dermatofibroma, and was later termed DFSP
15795 records 999/1053 page Previous Next First page 上5页 9969979989991000 下5页 Last page